Search research articles
Contact Us
Filters
Showing results (81-90 of 157) with videos related to
Page
of 16
Sort By:
Gynecologic Oncology
|
November 13, 2013
Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96
Janelle M Fauci, Francesco Sabbatino, Yangyang Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
May 3, 2011
Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation
Pallavi Garg, Shiqi Yang, Anguo Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation
Donald J Buchsbaum, James A Bonner, William E Grizzle, et al.
Cancer
|
March 6, 2002
Rationales, evidence, and design considerations for fractionated radioimmunotherapy
Gerald L DeNardo, Jeffery Schlom, Donald J Buchsbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein
Donald J Buchsbaum, M B Khazaeli, Donald B Axworthy, et al.
Gynecologic Oncology
|
January 8, 2011
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model
Kerri S Bevis, Lacey R McNally, Jeffery C Sellers, et al.
Radiology
|
May 9, 2002
Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice
Kurt R Zinn, Tandra R Chaudhuri, Victor N Krasnykh, et al.
The Journal of Biological Chemistry
|
December 2, 2017
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
Asmi Chakraborty, Kaitlyn A Dorsett, Hoa Q Trummell, et al.
Cancer Biology & Therapy
|
August 2, 2014
Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer
Hyunki Kim, Sharon L Samuel, Guihua Zhai, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2019
Histone deacetylase inhibition promotes intratumoral CD8<sup>+</sup> T-cell responses, sensitizing murine breast tumors to anti-PD1
Tyler R McCaw, Mei Li, Dmytro Starenki, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 157) with videos related to
Sort By:
Page
of 16
Gynecologic Oncology
|
November 13, 2013
Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96
Janelle M Fauci, Francesco Sabbatino, Yangyang Wang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology
|
May 3, 2011
Thrombospondin-1 opens the paracellular pathway in pulmonary microvascular endothelia through EGFR/ErbB2 activation
Pallavi Garg, Shiqi Yang, Anguo Liu, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 7, 2002
Treatment of pancreatic cancer xenografts with Erbitux (IMC-C225) anti-EGFR antibody, gemcitabine, and radiation
Donald J Buchsbaum, James A Bonner, William E Grizzle, et al.
Cancer
|
March 6, 2002
Rationales, evidence, and design considerations for fractionated radioimmunotherapy
Gerald L DeNardo, Jeffery Schlom, Donald J Buchsbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 22, 2005
Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein
Donald J Buchsbaum, M B Khazaeli, Donald B Axworthy, et al.
Gynecologic Oncology
|
January 8, 2011
Anti-tumor activity of an anti-DR5 monoclonal antibody, TRA-8, in combination with taxane/platinum-based chemotherapy in an ovarian cancer model
Kerri S Bevis, Lacey R McNally, Jeffery C Sellers, et al.
Radiology
|
May 9, 2002
Gamma camera dual imaging with a somatostatin receptor and thymidine kinase after gene transfer with a bicistronic adenovirus in mice
Kurt R Zinn, Tandra R Chaudhuri, Victor N Krasnykh, et al.
The Journal of Biological Chemistry
|
December 2, 2017
ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage
Asmi Chakraborty, Kaitlyn A Dorsett, Hoa Q Trummell, et al.
Cancer Biology & Therapy
|
August 2, 2014
Combination therapy with anti-DR5 antibody and tamoxifen for triple negative breast cancer
Hyunki Kim, Sharon L Samuel, Guihua Zhai, et al.
Cancer Immunology, Immunotherapy : CII
|
November 14, 2019
Histone deacetylase inhibition promotes intratumoral CD8<sup>+</sup> T-cell responses, sensitizing murine breast tumors to anti-PD1
Tyler R McCaw, Mei Li, Dmytro Starenki, et al.
Page
of 16